Data is being updated
Roll-call votes · EU Parliament
How François-Xavier voted.
Next plenary sitting: 5 October 2026 (in 8 days)
François-Xavier Bellamy
France FR
Speeches 119
Mandate 2024–2029
Voting Pattern –
Loading…
– – – –
Unable to load stats

François-Xavier Bellamy (EPP, France) — 2386 Roll-call votes · EU Parliament: 1849 For (77.5%), 226 Against (9.5%), 262 Abstention (11.0%), 49 Did not vote (2.1%).

Roll-call votes · EU Parliament

How François-Xavier Bellamy voted.

Next plenary sitting: 5 October 2026 (in 8 days)
Motion adopted

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795 (Motion adopted): 503 For, 57 Against, 108 Abstention, 67 Did not vote (735 Members). François-Xavier Bellamy: For.

20 Jan
2026
20. Jan 2026 · A10-0272/2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
A10-0272/2025
My vote For
For
503
Motion rejected

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795 (Motion rejected): 44 For, 600 Against, 13 Abstention, 78 Did not vote (735 Members). François-Xavier Bellamy: Against.

20 Jan
2026
20. Jan 2026 · A10-0272/2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
A10-0272/2025
My vote Against
Against
600
Motion adopted

Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006 (Motion adopted): 488 For, 67 Against, 34 Abstention, 224 Did not vote (813 Members). François-Xavier Bellamy: Abstention.

10 Apr
2024
10. Apr 2024 · A9-0141/2024
Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
A9-0141/2024
My vote Abstention
For
488
Showing 3 of 3
Follow us on Instagram @checksomevotes @checksomevotes_en